Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-8-29
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0003-0805
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
249-50
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1677552-Administration, Inhalation,
pubmed-meshheading:1677552-Adrenergic beta-Agonists,
pubmed-meshheading:1677552-Asthma,
pubmed-meshheading:1677552-Bronchodilator Agents,
pubmed-meshheading:1677552-Drug Administration Schedule,
pubmed-meshheading:1677552-Humans,
pubmed-meshheading:1677552-Nebulizers and Vaporizers
|
pubmed:year |
1991
|
pubmed:articleTitle |
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?
|
pubmed:publicationType |
Editorial
|